MARKET

PLSE

PLSE

Pulse Biosciences Inc
NASDAQ
20.75
+7.06
+51.57%
After Hours: 21.80 +1.05 +5.06% 19:59 02/06 EST
OPEN
14.95
PREV CLOSE
13.69
HIGH
20.80
LOW
14.61
VOLUME
2.84M
TURNOVER
--
52 WEEK HIGH
25.00
52 WEEK LOW
12.56
MARKET CAP
1.41B
P/E (TTM)
-18.2819
1D
5D
1M
3M
1Y
5Y
1D
Pulse Biosciences Inc. Files Initial Beneficial Ownership Statement for Director Maria Sainz
Reuters · 1d ago
Pulse Biosciences Heart Device Data Fuels Stock Surge
Benzinga · 1d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 1d ago
Pulse Biosciences Stock Surges on Positive Data from Cardiac Catheter Study
Dow Jones · 1d ago
Strategy Posts Upbeat Q4 Results, Joins SunOpta, BILL Holdings, Mitek Systems And Other Big Stocks Moving Higher On Friday
Benzinga · 1d ago
Pulse Biosciences price target raised to $30 from $25 at Mizuho
TipRanks · 2d ago
Pulse Biosciences Reports Strong nPulse Atrial Fibrillation Study Results
TipRanks · 2d ago
Reported Earlier, Pulse Biosciences Highlights nPulse Cardiac Catheter Ablation Study Achieving Durable AF Treatment Outcomes With Average Procedure Time Of 65 Minutes And Low SAE Rate
Benzinga · 2d ago
More
About PLSE
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s CellFX Nanosecond Pulsed-Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. It is pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation (AF) and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers, such as surgical soft tissue ablation. Its nsPFA Percutaneous Electrode System consists of a disposable, percutaneous, needle electrode for use with its CellFX Console. Its surgical cardiac ablation clamp is designed for use by cardiac surgeons during the surgical treatment of AF. The CellFX Console is a tunable, software-enabled, console-based platform, designed to accommodate the clinical workflow preferred by physicians. It is also developing a Nanosecond PFA 360-degree Cardiac Catheter System.

Webull offers Pulse Biosciences Inc stock information, including NASDAQ: PLSE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLSE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLSE stock methods without spending real money on the virtual paper trading platform.